The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB&M Regulatory News (BME)

Share Price Information for B&M (BME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 521.60
Bid: 521.80
Ask: 522.20
Change: 4.60 (0.89%)
Spread: 0.40 (0.077%)
Open: 519.80
High: 525.00
Low: 517.20
Prev. Close: 517.00
BME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed placing of shares

23 Jul 2015 16:45

RNS Number : 9522T
BofA Merrill Lynch
23 July 2015
 



Proposed placing of shares in B&M European Value Retail S.A.

NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA.

23 July 2015

PROPOSED PLACING OF UP TO 120,000,000 ORDINARY SHARES IN B&M EUROPEAN VALUE RETAIL S.A. ("B&M") BY CD&R EUROPEAN VALUE RETAIL INVESTMENT S.À R.L. ("CD&R") AND SSA INVESTMENTS S.À R.L. ("SSA INVESTMENTS")

CD&R and SSA Investments, the Arora family investment vehicle, announce their intention to sell up to 120,000,000 ordinary shares in B&M (the "Placing Shares") (the "Placing"). The Placing Shares represent approximately 12% of B&M's issued ordinary share capital. Following the sale, CD&R expects to retain approximately 11% and SSA Investments expects to retain, directly and indirectly, approximately 21% of the issued share capital of B&M.

The Placing Shares are being offered to institutional investors by way of an accelerated bookbuild, which will be launched immediately following this announcement. Merrill Lynch International ("BofA Merrill Lynch"), Goldman Sachs International and Numis Securities Limited ("Numis") are acting as Joint Bookrunners in connection with the Placing. Lazard & Co., Limited ("Lazard") is acting as financial adviser to CD&R and SSA Investments in connection with the Placing.

The price at which the Placing Shares are to be placed will be agreed by the Joint Bookrunners, CD&R and SSA Investments at the close of the bookbuild process, and will be announced as soon as practicable thereafter.

Simon and Bobby Arora remain fully committed to the business and are confident in the outlook for B&M both in the UK and internationally. SSA Investments' participation in the transaction will provide further liquidity in B&M, and the proceeds from the sale will be used to diversify the Aroras' investment portfolio. SSA Investments remains B&M's largest shareholder and is committed to participating in B&M's exciting future growth prospects.

CD&R reiterates its support and confidence in B&M's management team to successfully implement the company's growth strategy.

CD&R has undertaken that, without the prior written consent of the Joint Bookrunners and subject to certain customary exceptions, it will not dispose of any further B&M shares for a period of 90 days following completion of the Placing.

SSA Investments has undertaken that, without the prior written consent of the Joint Bookrunners and subject to certain customary exceptions, it will not dispose of any further B&M shares for a period of 180 days following completion of the Placing.

B&M will not receive any proceeds from the Placing.

Enquiries:

For further information, please contact:

BofA Merrill Lynch +44 (0) 20 7628 1000

Craig Coben

Daniel Burton-Morgan

George Close-Brooks

 

Goldman Sachs International +44 (0)20 7774 1000

Richard Cormack

Giacomo Ciampolini

 

Numis +44 (0)20 7260 1000

Alex Ham

Michael Burke

Jamie Loughborough

 

Lazard +44 (0)20 7187 2000

Charlie Foreman

Nick Fowler

 

IMPORTANT NOTICE:

This announcement is not for publication, distribution or release, directly or indirectly, in or into the United States of America (including its territories and possessions), Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where such an announcement would be unlawful. The distribution of this announcement may be restricted by law in certain jurisdictions and persons into whose possession this document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement is not an offer of securities or investments for sale nor a solicitation of an offer to buy securities or investments in any jurisdiction where such offer or solicitation would be unlawful. No action has been taken that would permit an offering of the securities or possession or distribution of this announcement in any jurisdiction where action for that purpose is required. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

The Placing Shares may not be offered to the public in any jurisdiction in circumstances which would require the preparation or registration of any prospectus or offering document relating to the Placing Shares in such jurisdiction. No action has been taken by CD&R European Value Retail Investment S.à r.l., SSA Investments S.à r.l. or any of their respective affiliates that would permit an offering of the Placing Shares or possession or distribution of this announcement or any other offering or publicity material relating to such securities in any jurisdiction where action for that purpose is required.

The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), and, subject to certain exemptions, may not be offered or sold in the United States (as defined in Regulation S under the Securities Act). Neither this document nor the information contained herein constitutes or forms part of an offer to sell or the solicitation of an offer to buy securities in the United States. There will be no public offer of any securities in the United States or in any other jurisdiction.

In member states of the European Economic Area ("EEA") which have implemented the Prospectus Directive (each, a "Relevant Member State"), this announcement and any offer if made subsequently is directed exclusively at persons who are 'qualified investors' within the meaning of the Prospectus Directive ("Qualified Investors"). For these purposes, the expression 'Prospectus Directive' means Directive 2003/71/EC (and amendments thereto, including the 2010 PD Amending Directive, to the extent implemented in a Relevant Member State), and includes any relevant implementing measure in the Relevant Member State and the expression "2010 PD Amending Directive" means Directive 2010/73/EU. In the United Kingdom, this announcement is directed exclusively at Qualified Investors (i) who have professional experience in matters relating to investments falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order") or (ii) who fall within Article 49(2)(A) to (D) of the Order, or (iii) to whom it may otherwise lawfully be communicated.

In connection with any offering of the Placing Shares, BofA Merrill Lynch, Goldman Sachs International, Numis and any of their affiliates acting as an investor for their own account may take up as a proprietary position any Placing Shares and in that capacity may retain, purchase or sell for their own account such Placing Shares. In addition they may enter into financing arrangements and swaps with investors in connection with which they may from time to time acquire, hold or dispose of Placing Shares. They do not intend to disclose the extent of any such investment or transactions otherwise than in accordance with any legal or regulatory obligation to do so.

BofA Merrill Lynch and Goldman Sachs International, which are authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority, and Numis, which is authorised and regulated by the Financial Conduct Authority, are acting on behalf of CD&R and SSA Investments and no one else in connection with any offering of the Placing Shares and will not be responsible to any other person for providing the protections afforded to any of its clients or for providing advice in relation to any offering of the Placing Shares. BofA Merrill Lynch, Goldman Sachs International and Numis will not regard any other person as its client in relation to the offering of the Placing Shares.

Lazard, which is authorised and regulated by Financial Conduct Authority, is acting exclusively for CD&R and SSA Investments and no one else in connection with the Placing and will not regard any other person as its client in relation to the Placing and will not be responsible to anyone other than CD&R and SSA Investments for providing the protections afforded to its clients or for giving advice in relation to the Placing or the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSEDVIVFIE
Date   Source Headline
4th Dec 20207:00 amRNSResult of EGM
3rd Dec 20204:20 pmRNSTrading Update
17th Nov 202012:39 pmRNSDirector/PDMR Shareholding
16th Nov 202011:12 amRNSDirector/PDMR Shareholding
13th Nov 202012:35 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSHalf-year Report
28th Oct 20207:00 amRNSNotice of EGM
30th Sep 20209:36 amRNSTotal Voting Rights
29th Sep 20207:00 amRNSTrading Update
21st Sep 20209:53 amRNSResult of AGM
1st Sep 20209:40 amRNSTotal Voting Rights
30th Jul 202011:20 amRNSDirector/PDMR Shareholding
28th Jul 20207:00 amRNSTrading Statement
20th Jul 20209:00 amRNSPost Stabilisation Notice
14th Jul 20209:50 amRNSDirector/PDMR Shareholding
13th Jul 20209:09 amRNSBlock listing Interim Review
9th Jul 20202:28 pmRNSBoard Changes
7th Jul 20204:05 pmRNSHolding(s) in Company
7th Jul 20209:01 amRNSHolding(s) in Company
2nd Jul 20206:19 pmRNSPricing of Senior Secured Notes Offering
1st Jul 202011:07 amRNSPre Stabilisation Notice
1st Jul 20209:02 amRNSLaunch of Senior Secured Notes Offering
1st Jul 20207:00 amRNSTrading Statement
1st Jul 20207:00 amRNSAnnual Financial Report
17th Jun 202011:38 amRNSDirector/PDMR Shareholding
11th Jun 20207:00 amRNSPreliminary Results
29th May 20207:00 amRNSTrading Update
27th May 20209:57 amRNSHolding(s) in Company
1st Apr 20204:17 pmRNSHolding(s) in Company
1st Apr 202012:29 pmRNSCovid-19 Update
27th Mar 202012:05 pmRNSCompletion of Disposal
25th Mar 20202:50 pmRNSHolding(s) in Company
19th Mar 20202:42 pmRNSHolding(s) in Company
11th Mar 20207:00 amRNSDisposal
6th Mar 20206:02 pmRNSSpecial Dividend
3rd Mar 20207:00 amRNSBoard Changes
24th Feb 20209:54 amRNSHolding(s) in Company
14th Jan 202010:10 amRNSHolding(s) in Company
13th Jan 202010:00 amRNSBlock listing Interim Review
10th Jan 20207:00 amRNSTrading Statement
11th Dec 201911:10 amRNSHolding(s) in Company
11th Dec 201911:01 amRNSHolding(s) in Company
2nd Dec 201910:33 amRNSTotal Voting Rights
12th Nov 20197:00 amRNSHalf-year Report
16th Oct 201912:50 pmRNSBoard Retirement
2nd Aug 20193:28 pmRNSDirector/PDMR Shareholding
31st Jul 20199:14 amRNSHolding(s) in Company
29th Jul 201910:40 amRNSResult of AGM
25th Jul 20197:00 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.